A plain language summary looking at the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer
This Plain Language Summary of Publication article (PLSP) from Future Oncology looks at the results of a study called PHAROS. The study looked at how well a combination treatment of encorafenib and binimetinib could treat people with metastatic mon-small-cell lung cancer (NSCLC).
Visit the Future Medicine using the link to read the article.
This PLSP is based on an original article called ‘Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non–Small-Cell Lung Cancer’ and was published in the Journal of Clinical Oncology.
Visit ASCO Publications using the link to read the article.